Premium
A novel paclitaxel‐eluting dedicated bifurcation stent: A case report from the first human use Taxus Petal trial
Author(s) -
Johnson Thomas W.,
Kay I. Patrick,
Ormiston John A.
Publication year - 2009
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.21943
Subject(s) - medicine , paclitaxel , taxus , stent , petal , cancer , botany , biology
A dedicated bifurcation stent has the potential to simplify and improve the outcomes of percutaneous coronary bifurcation intervention. We report a patient from the first human use trial of a novel paclitaxel‐eluting dedicated bifurcation stent. By 6 months, there were no adverse events and the stent lumen and, in particular, the side‐branch ostium were widely patent on angiography and intravascular ultrasound. This device may offer superior results without the limitations of conventional stent techniques in the treatment of coronary bifurcation disease. © 2008 Wiley‐Liss, Inc.